共 160 条
[1]
Kochi A., The global tuberculosis situation and the new control strategy of the World Health Organisation, Tubercle, 72, pp. 1-6, (1991)
[2]
Fox W., Tuberculosis in India, past, present and future, Indian J Tuberculosis, 37, (1990)
[3]
Girling D.J., Adverse effects of antituberculosis drugs, Drugs, 23, pp. 56-74, (1982)
[4]
Pannier R., Drug induced lung disease, Eur J Respir Dis, 64, 126, (1983)
[5]
Antituberculosis regimens of chemotherapy. Recommendation from the committee on treatment of IUALTD, Bull Int Union Tuberc Lung Dis, 63, 2, pp. 60-64, (1988)
[6]
Wong C.T., Saha N., Changes in serum proteins (albumin, immunoglobulins and acute phase proteins) in pulmonary tuberculosis during therapy, Tubercle, 71, (1990)
[7]
Hawkins J.E., Drug susceptibility testing, The mycobacteria. A sourcebook. Part A, (1984)
[8]
Fox W., Drug combinations and the bioavailability of rifampicin, Tubercle, 71, (1990)
[9]
Acocella G., Human bioavailability studies, Bull Int Union Tuberc Lung Dis, 64, pp. 38-40, (1989)
[10]
TM, Avery’s drug treatment: principles and practice of clinical pharmacology and therapeutics, (1987)

